LABORATORIO FARMAC.ERFO Net Asset Momentum
LABORATORIO FARMAC.ERFO net asset momentum. LABORATORIO FARMAC.ERFO (RK7) recorded a net asset momentum of N/A as of December 2023, with net assets of €7.88 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore LABORATORIO FARMAC.ERFO capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of LABORATORIO FARMAC.ERFO (2021–2023)
Net asset momentum of LABORATORIO FARMAC.ERFO from 2021 to 2023. This chart tracks LABORATORIO FARMAC.ERFO's year-over-year net asset growth across 3 annual reporting periods from 2021 to 2023. See net assets of LABORATORIO FARMAC.ERFO for net asset value and shareholders' equity analysis.
LABORATORIO FARMAC.ERFO Net Asset Momentum by Year (2021–2023)
LABORATORIO FARMAC.ERFO net asset momentum by year from 2021 to 2023. The table below shows the complete annual net asset history for LABORATORIO FARMAC.ERFO from 2021 to 2023, covering 3 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see LABORATORIO FARMAC.ERFO (RK7) total market value.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2023 | €7.88 Million | €10.15 Million | €2.26 Million | — |
| 2022 | €0.00 | €10.53 Million | €10.53 Million | ▼ -100.0% |
| 2021 | €4.73 Million | €6.93 Million | €2.21 Million | — |